CurrentCardio
Get Weekly

CurrentCardio coverage · page 9 of 11

JACC: Cardiovascular Interventions

Briefs 321–360 of 433 CurrentCardio has covered from this journal, newest publication first

Latest from JACC: Cardiovascular Interventions

All coverage, newest first

  1. JACC Cardiovasc Interv

    Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction

    Cross-sectional studyCoronary & ACS

  2. JACC Cardiovasc Interv

    Mitral Valve Transcatheter Edge-to-Edge Repair: 1-Year Outcomes From the MiCLASP Study

    Cohort studyValvular & structural

  3. JACC Cardiovasc Interv

    Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE

    Cohort studyValvular & structural

  4. JACC Cardiovasc Interv

    Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series

    Research articlePrevention & lipids

  5. JACC Cardiovasc Interv

    P2Y12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study

    Randomised controlled trialCoronary & ACS

  6. JACC Cardiovasc Interv

    Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

    Meta-analysisValvular & structural

  7. JACC Cardiovasc Interv

    Chimney Stenting vs BASILICA for Prevention of Acute Coronary Obstruction During Transcatheter Aortic Valve Replacement

    Cohort studyValvular & structural

  8. JACC Cardiovasc Interv

    Prognostic Implications of Microvascular Resistance Reserve in Symptomatic Patients With Intermediate Coronary Stenosis

    Cohort studyCoronary & ACS

  9. JACC Cardiovasc Interv

    National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement

    Cohort studyCoronary & ACS

  10. JACC Cardiovasc Interv

    Evolut PRO and SAPIEN ULTRA Performance in Small Aortic Annuli: The OPERA-TAVI Registry

    Cohort studyValvular & structural

  11. JACC Cardiovasc Interv

    Inter-Rater Reliability for the Amputation Endpoint in the National Vascular Quality Initiative

    Diagnostic or prognostic studyAortic & peripheral

  12. JACC Cardiovasc Interv

    The Impact of Cerebral Embolic Protection Devices on Characteristics and Outcomes of Stroke Complicating TAVR

    Cohort studyValvular & structural

  13. JACC Cardiovasc Interv

    Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions

    Secondary analysisAortic & peripheral

  14. JACC Cardiovasc Interv

    Real-World Outcomes for the Fifth-Generation Balloon Expandable Transcatheter Heart Valve in the United States

    Cohort studyValvular & structural

  15. JACC Cardiovasc Interv

    Coronary Cannulation Following TAVR Using Self-Expanding Devices With Commissural Alignment: The RE-ACCESS 2 Study

    Cohort studyValvular & structural

  16. JACC Cardiovasc Interv

    Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry

    Cohort studyValvular & structural

  17. JACC Cardiovasc Interv

    Coronary Vasomotor Dysfunction Is Associated With Cardiovascular Events in Patients With Nonobstructive Coronary Artery Disease

    Cohort studyCoronary & ACS

  18. JACC Cardiovasc Interv

    Association Between Clinical Trial Participation Status and Outcomes With Mitral Transcatheter Edge-to-Edge Repair

    Cohort studyValvular & structural

  19. JACC Cardiovasc Interv

    Transapical Mitral Valve Replacement: 1-Year Results of the Real-World Tendyne European Experience Registry

    Cohort studyValvular & structural

  20. JACC Cardiovasc Interv

    A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study

    Cohort studyCoronary & ACS

  21. JACC Cardiovasc Interv

    National Variability in Pacemaker Implantation Rate Following TAVR: Insights From the STS/ACC TVT Registry

    Cohort studyValvular & structural

  22. JACC Cardiovasc Interv

    Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention

    Cohort studyCoronary & ACS

  23. JACC Cardiovasc Interv

    Non–Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement

    Cohort studyValvular & structural

  24. JACC Cardiovasc Interv

    Distal Radial Access for Coronary Procedures in a Large Prospective Multicenter Registry: The KODRA Trial

    Cohort studyCoronary & ACS

  25. JACC Cardiovasc Interv

    Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions

    Cohort studyCoronary & ACS

  26. JACC Cardiovasc Interv

    National Variation in Hospital MTEER Outcomes and Correlation With TAVR Outcomes: STS/ACC TVT Registry Analysis

    Cohort studyValvular & structural

  27. JACC Cardiovasc Interv

    Right Heart Reverse Remodeling and Prosthetic Valve Function After Transcatheter vs Surgical Pulmonary Valve Replacement

    Cohort studyValvular & structural

  28. JACC Cardiovasc Interv

    Transcatheter Pulmonary Valve Replacement With Balloon-Expandable Valves: Utilization and Procedural Outcomes From the IMPACT Registry

    Cohort studyValvular & structural

  29. JACC Cardiovasc Interv

    Safety and Efficacy of Combining Left Atrial Appendage Occlusion With Another Cardiac Procedure

    Cohort studyArrhythmias & EP

  30. JACC Cardiovasc Interv

    Below-the-Knee Endovascular Revascularization: A Position Statement

    Guideline or statementAortic & peripheral

  31. JACC Cardiovasc Interv

    Transcatheter Paravalvular Leak Closure With Covered Stent Tract and Vascular Plug: Tootsie Roll Technique

    Cohort studyValvular & structural

  32. JACC Cardiovasc Interv

    Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease

    Meta-analysisCoronary & ACS

  33. JACC Cardiovasc Interv

    Atrial Functional Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement

    Cohort studyValvular & structural

  34. JACC Cardiovasc Interv

    Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction: Insights From the Bern-PCI Registry

    Cohort studyCoronary & ACS

  35. JACC Cardiovasc Interv

    Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

    Cohort studyValvular & structural

  36. JACC Cardiovasc Interv

    Long-Term Risk of Stroke After Transcatheter Aortic Valve Replacement: Insights From the SwissTAVI Registry

    Cohort studyValvular & structural

  37. JACC Cardiovasc Interv

    Pulmonary Valve Replacement in Tetralogy of Fallot: Procedural Volume and Durability of Bioprosthetic Pulmonary Valves

    Cohort studyCongenital

  38. JACC Cardiovasc Interv

    Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal Lesions

    Randomised controlled trialAortic & peripheral

  39. JACC Cardiovasc Interv

    Implications of Mitral Annular Disjunction in Patients Undergoing Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation

    Cohort studyValvular & structural

  40. JACC Cardiovasc Interv

    Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes

    Cohort studyValvular & structural

All 433 Briefs in ExploreShowing Briefs 321–360 of 433, newest first